PerkinElmer, Inc., (Waltham, Massachusetts, USA) has built a personalized health innovation centre of excellence.
PerkinElmer, Inc., (Waltham, Massachusetts, USA) has built a personalized health innovation centre of excellence. The centre will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and longevity of life.
The centre will bring together leaders from PerkinElmer’s chemistry, biochemistry, cell biology, molecular biology and reagent development R&D teams. They will focus on the development of applications solutions in genomics, imaging, biomarkers, biotherapeutics, targeted small molecule development and cell‑based assay solutions. The centre will also showcase a complete solutions-based demonstration laboratory for customers and collaborators.
The centre will be located at the company’s facility in Hopkinton, Massachusetts, USA, and is hoped to be fully operational by late 2012.Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer, said, “We are delighted to establish our new centre of excellence, which will serve as an exciting example of PerkinElmer’s commitment to, and culture of, innovation. The expertise promoted by the centre will help bring novel and disruptive solutions to our customers, aiding their research in next generation treatments, early detection and disease prevention.”
For more information please visit www.perkinelmer.comThis story originally appeared in The Column. Click here to view that issue.
Analysis of Greenhouse Gases by Gas Chromatography
May 15th 2024This application note demonstrates the use of SCION's 8500GC system for the analysis of key greenhouse gases—carbon dioxide, methane, and nitrous oxide—in a single atmospheric air matrix. Highlighting the system's excellent sensitivity and repeatability, this method is crucial for understanding emission sources and combating climate change.
Analysis of DEHP in Drinking Water by HPLC-DAD
May 15th 2024This application note outlines a method for detecting low levels of 1,4-Dioxane, a likely carcinogenic compound, in drinking water using SCION GC-MS technology. It details the procedure for analyzing water samples spiked with 1,4-Dioxane, achieving excellent sensitivity and low detection limits, demonstrating the method's effectiveness for environmental monitoring.